216 related articles for article (PubMed ID: 29227213)
1. Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.
Van Blarcom T; Lindquist K; Melton Z; Cheung WL; Wagstrom C; McDonough D; Valle Oseguera C; Ding S; Rossi A; Potluri S; Sundar P; Pitts S; Sirota M; Galindo Casas M; Yan Y; Jones J; Roe-Zurz Z; Srivatsa Srinivasan S; Zhai W; Pons J; Rajpal A; Chaparro-Riggers J
MAbs; 2018; 10(2):256-268. PubMed ID: 29227213
[TBL] [Abstract][Full Text] [Related]
2. Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.
Kim HS; Dunshee DR; Yee A; Tong RK; Kim I; Farahi F; Hongo JA; Ernst JA; Sonoda J; Spiess C
Protein Eng Des Sel; 2017 Sep; 30(9):627-637. PubMed ID: 28985411
[TBL] [Abstract][Full Text] [Related]
3. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.
Ching KH; Berg K; Reynolds K; Pedersen D; Macias A; Abdiche YN; Harriman WD; Leighton PA
MAbs; 2021; 13(1):1862451. PubMed ID: 33491549
[TBL] [Abstract][Full Text] [Related]
4. Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.
Fischer N; Elson G; Magistrelli G; Dheilly E; Fouque N; Laurendon A; Gueneau F; Ravn U; Depoisier JF; Moine V; Raimondi S; Malinge P; Di Grazia L; Rousseau F; Poitevin Y; Calloud S; Cayatte PA; Alcoz M; Pontini G; Fagète S; Broyer L; Corbier M; Schrag D; Didelot G; Bosson N; Costes N; Cons L; Buatois V; Johnson Z; Ferlin W; Masternak K; Kosco-Vilbois M
Nat Commun; 2015 Feb; 6():6113. PubMed ID: 25672245
[TBL] [Abstract][Full Text] [Related]
5. Engineering bispecific antibodies with defined chain pairing.
Krah S; Sellmann C; Rhiel L; Schröter C; Dickgiesser S; Beck J; Zielonka S; Toleikis L; Hock B; Kolmar H; Becker S
N Biotechnol; 2017 Oct; 39(Pt B):167-173. PubMed ID: 28137467
[TBL] [Abstract][Full Text] [Related]
6. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
[TBL] [Abstract][Full Text] [Related]
7. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
[TBL] [Abstract][Full Text] [Related]
8. Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974.
Shiraiwa H; Narita A; Kamata-Sakurai M; Ishiguro T; Sano Y; Hironiwa N; Tsushima T; Segawa H; Tsunenari T; Ikeda Y; Kayukawa Y; Noguchi M; Wakabayashi T; Sakamoto A; Konishi H; Kuramochi T; Endo M; Hattori K; Nezu J; Igawa T
Methods; 2019 Feb; 154():10-20. PubMed ID: 30326272
[TBL] [Abstract][Full Text] [Related]
9. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
Tustian AD; Endicott C; Adams B; Mattila J; Bak H
MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
[TBL] [Abstract][Full Text] [Related]
10. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
[TBL] [Abstract][Full Text] [Related]
11. Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling.
Jackman J; Chen Y; Huang A; Moffat B; Scheer JM; Leong SR; Lee WP; Zhang J; Sharma N; Lu Y; Iyer S; Shields RL; Chiang N; Bauer MC; Wadley D; Roose-Girma M; Vandlen R; Yansura DG; Wu Y; Wu LC
J Biol Chem; 2010 Jul; 285(27):20850-9. PubMed ID: 20444694
[TBL] [Abstract][Full Text] [Related]
12. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
13. Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells.
Dillon M; Yin Y; Zhou J; McCarty L; Ellerman D; Slaga D; Junttila TT; Han G; Sandoval W; Ovacik MA; Lin K; Hu Z; Shen A; Corn JE; Spiess C; Carter PJ
MAbs; 2017; 9(2):213-230. PubMed ID: 27929752
[TBL] [Abstract][Full Text] [Related]
14. LUZ-Y, a novel platform for the mammalian cell production of full-length IgG-bispecific antibodies.
Wranik BJ; Christensen EL; Schaefer G; Jackman JK; Vendel AC; Eaton D
J Biol Chem; 2012 Dec; 287(52):43331-9. PubMed ID: 23118228
[TBL] [Abstract][Full Text] [Related]
15. Engineering therapeutic bispecific antibodies using CrossMab technology.
Klein C; Schaefer W; Regula JT; Dumontet C; Brinkmann U; Bacac M; Umaña P
Methods; 2019 Feb; 154():21-31. PubMed ID: 30453028
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry.
Schachner L; Han G; Dillon M; Zhou J; McCarty L; Ellerman D; Yin Y; Spiess C; Lill JR; Carter PJ; Sandoval W
Anal Chem; 2016 Dec; 88(24):12122-12127. PubMed ID: 28193052
[TBL] [Abstract][Full Text] [Related]
17. Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.
Dimasi N; Fleming R; Sachsenmeier KF; Bezabeh B; Hay C; Wu J; Sult E; Rajan S; Zhuang L; Cariuk P; Buchanan A; Bowen MA; Wu H; Gao C
MAbs; 2017 Apr; 9(3):438-454. PubMed ID: 28055299
[TBL] [Abstract][Full Text] [Related]
18. Rational selection of building blocks for the assembly of bispecific antibodies.
Gong D; Riley TP; Bzymek KP; Correia AR; Li D; Spahr C; Robinson JH; Case RB; Wang Z; Garces F
MAbs; 2021; 13(1):1870058. PubMed ID: 33397191
[TBL] [Abstract][Full Text] [Related]
19. Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface.
Lewis SM; Wu X; Pustilnik A; Sereno A; Huang F; Rick HL; Guntas G; Leaver-Fay A; Smith EM; Ho C; Hansen-Estruch C; Chamberlain AK; Truhlar SM; Conner EM; Atwell S; Kuhlman B; Demarest SJ
Nat Biotechnol; 2014 Feb; 32(2):191-8. PubMed ID: 24463572
[TBL] [Abstract][Full Text] [Related]
20. Optimizing assembly and production of native bispecific antibodies by codon de-optimization.
Magistrelli G; Poitevin Y; Schlosser F; Pontini G; Malinge P; Josserand S; Corbier M; Fischer N
MAbs; 2017; 9(2):231-239. PubMed ID: 28001485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
